Clinical Trial Update: Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy [Phase 1]

View source ↗

Summary

Phase 1 trial of a neoantigen peptide vaccine strategy in pancreatic cancer patients following surgical resection and adjuvant chemotherapy was terminated, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Neoantigen peptide vaccine

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pancreas Cancer, Pancreatic Cancer | Phase 1 | Status: TERMINATED | Results posted: 2023-05-31